Inside the Pharmaceutical Journal
As all sectors of pharmacy are being put under immense pressure to maintain patient care, Tony Scully writes to reassure readers that we are doing everything we can to deliver supportive, up-to-date content.
The Pharmaceutical Journal wasn’t short of strong views this year — whether it was a criticism of clinical guidance or a defence of the pharmacy profession. Here are the opinions that resonated most with you in 2019.
Among our most-read features in 2019 was an investigation into whether pharmacists are dispensing too many multicompartment compliance aids, and another on why thousands of patients are being left on potentially risky drug combinations involving anticoagulants.
Another year may have flown by, but that does not mean pharmacy professionals have not been investing time to lay important foundations for a thriving career.
Medicines-related harm is an issue close to the hearts of all of those who work in pharmacy, making our infographic on medication errors the most popular of 2019.
This year, our peer-reviewed research papers received more than 400,000 unique page views.
Our research briefings are concise and informative; they keep readers up to date with the latest developments in science and clinical research — from novel uses for existing drugs, to studies assessing potential new treatments.
The Pharmaceutical Journal has been a vital resource for pharmacists in 2019, with a staggering 3.5 million page views across our learning and CPD articles — up 38% from 2018.
There have been big changes across the Royal Pharmaceutical Society (RPS) in 2019: it has been a year of new faces, new campaigns, new publications and, for the RPS in Scotland, a new home.
Based on feedback from RPS members, you will soon receive one combined print journal per month.
The Pharmaceutical Journal is asking readers to write a short piece on the theme of ‘The patient who change my practice’, where the winning entry will receive an Amazon Fire 8 tablet.
In February 2019, The Pharmaceutical Journal is celebrating pharmacists’ contribution to improving medicines safety in the UK.
This year, articles exploring pharmacy’s role in antimicrobial stewardship, as well as original research articles on integrated pharmacy services and medicines optimisation in care homes, feature among the most popular.
Features can be timeless articles on an aspect of drug development, pharmacy practice or medicines optimisation, or topical pieces that delve further into news stories to give context and analysis. It has been an interesting year in pharmacy, from the rescheduling of cannabis to the patent expiry of the NHS’s most costly drug, and the magazine’s features section reflects this, and much more.
With the Falsified Medicines Directive (FMD) due to come into force in February 2019 (with the caveat of a Brexit deal, of course), it’s no surprise that our infographic explaining how FMD will work was the most read of those published in 2018. Other topics that made it to the top five include medical cannabis and our salary and satisfaction survey.
In 2018, our most popular research briefings covered new areas of research that have been particularly topical this year — including medical cannabis, new antibiotics and e-cigarettes — as well as areas that have long been of interest to pharmacists, such as pain management and adherence.
Access to medicines has been a big theme for 2018 — from new legal access to medical cannabis treatment options, to fears that price hikes and Brexit are jeopardising the supply of medicines to patients who are already dependent on them.
With nearly 2 million page views in 2018, our learning section has gone from strength to strength this year and has seen a 20.5% increase in page views compared with 2017.
It’s been a busy year for the Royal Pharmaceutical Society (RPS). The Society co-hosted the 2018 International Pharmaceutical Federation (FIP) Congress, which saw more than 3,000 delegates from 107 countries gather in Glasgow during 2–6 September. The Society used the congress to launch its professional development core curriculum, the product of five years’ work to help support pharmacists through their career development.
Catch up on this year’s most read clinical trial stories, many of which cover important research into adverse effects of commonly used drugs.